Biophysical analysis of drug efficacy on C. elegans models for neurodegenerative and neuromuscular diseases.
Caenorhabditis elegans has emerged as a powerful model organism for drug screening due to its cellular simplicity, genetic amenability and homology to humans combined with its small size and low cost. Currently, high-throughput drug screening assays are mostly based on image-based phenotyping with t...
Guardado en:
Autores principales: | Samuel Sofela, Sarah Sahloul, Yong-Ak Song |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc0b9aa926da4040928a759eec182632 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sirtuins and Autophagy in Age-Associated Neurodegenerative Diseases: Lessons from the <i>C. elegans</i> Model
por: Anam Naseer, et al.
Publicado: (2021) - Neuromuscular Diseases
-
High-throughput behavioral screen in C. elegans reveals Parkinson’s disease drug candidates
por: Salman Sohrabi, et al.
Publicado: (2021) -
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
por: Claudia Riccardi, et al.
Publicado: (2021) -
Genetic variants associated with neurodegenerative Alzheimer disease in natural models
por: Salazar,Claudia, et al.
Publicado: (2016)